BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35079246)

  • 1. Two different sizes of Valencia applicators in non-melanoma skin cancer treatment with iridium-192 high-dose-rate brachytherapy.
    Laliscia C; Coccia N; Fuentes T; Perrone F; Paiar F
    J Contemp Brachytherapy; 2021 Dec; 13(6):615-619. PubMed ID: 35079246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose-rate brachytherapy for non-melanoma skin cancer using tailored custom moulds - a single-centre experience.
    Laliscia C; Fuentes T; Coccia N; Mattioni R; Perrone F; Paiar F
    Contemp Oncol (Pozn); 2021; 25(1):12-16. PubMed ID: 33911976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-melanoma skin cancer treated with high-dose-rate brachytherapy and Valencia applicator in elderly patients: a retrospective case series.
    Delishaj D; Laliscia C; Manfredi B; Ursino S; Pasqualetti F; Lombardo E; Perrone F; Morganti R; Paiar F; Fabrini MG
    J Contemp Brachytherapy; 2015 Dec; 7(6):437-44. PubMed ID: 26816500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-melanoma skin cancer treated with HDR Valencia applicator: clinical outcomes.
    Tormo A; Celada F; Rodriguez S; Botella R; Ballesta A; Kasper M; Ouhib Z; Santos M; Perez-Calatayud J
    J Contemp Brachytherapy; 2014 Jun; 6(2):167-72. PubMed ID: 25097557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDR brachytherapy for superficial non-melanoma skin cancers.
    Gauden R; Pracy M; Avery AM; Hodgetts I; Gauden S
    J Med Imaging Radiat Oncol; 2013 Apr; 57(2):212-7. PubMed ID: 23551783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Custom mold applicator high-dose-rate brachytherapy for nonmelanoma skin cancer-An analysis of 273 lesions.
    Olek D; El-Ghamry MN; Deb N; Thawani N; Shaver C; Mutyala S
    Brachytherapy; 2018; 17(3):601-608. PubMed ID: 29398593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and cosmetic outcomes in patients treated with high-dose-rate electronic brachytherapy for nonmelanoma skin cancer.
    Paravati AJ; Hawkins PG; Martin AN; Mansy G; Rahn DA; Advani SJ; Hoisak J; Dragojevic I; Martin PJ; Miller CJ; Sanghvi P
    Pract Radiat Oncol; 2015; 5(6):e659-64. PubMed ID: 26432680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose-rate brachytherapy in the treatment of skin Kaposi sarcoma.
    Ruiz MÁG; Rivero JQ; García JLM; Rodríguez JJC; Kavadoy YR; Carmona MFR; Campos AC; Urra FG; Muñoz MCC; Herrero AR; Manzano PA
    J Contemp Brachytherapy; 2017 Dec; 9(6):561-565. PubMed ID: 29441101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High dose rate brachytherapy with customized applicators for malignant facial skin lesions.
    Jumeau R; Renard-Oldrini S; Courrech F; Buchheit I; Oldrini G; Vogin G; Peiffert D
    Cancer Radiother; 2016 Jul; 20(5):341-6. PubMed ID: 27321412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The initial experience of electronic brachytherapy for the treatment of non-melanoma skin cancer.
    Bhatnagar A; Loper A
    Radiat Oncol; 2010 Sep; 5():87. PubMed ID: 20875139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor control and cosmetic outcome of weekly iridium-192 high-dose-rate brachytherapy for nonmelanoma skin cancers in the elderly.
    Roberson J; Patel R; Slutsky JB; Ryu S; Xu Z; Valentine E
    Brachytherapy; 2021; 20(4):818-827. PubMed ID: 33789824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of literature.
    Delishaj D; Rembielak A; Manfredi B; Ursino S; Pasqualetti F; Laliscia C; Orlandi F; Morganti R; Fabrini MG; Paiar F
    J Contemp Brachytherapy; 2016 Dec; 8(6):533-540. PubMed ID: 28115960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose-rate skin brachytherapy with interstitial, surface, or a combination of interstitial and surface mold technique.
    Brovchuk S; Park SJ; Shepil Z; Romanenko S; Vaskevych O
    J Contemp Brachytherapy; 2022 Apr; 14(2):107-114. PubMed ID: 35494184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose-rate brachytherapy using Leipzig applicators for non-melanoma localized skin cancer.
    Pellizzon ACA; Fogaroli R; Chen MJ; Maia P; Gondim G; Guedes DC; Ramos H; Silva MLG
    J Contemp Brachytherapy; 2020 Oct; 12(5):435-440. PubMed ID: 33299432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electronic brachytherapy for treatment of non-melanoma skin cancers: clinical results and toxicities.
    Goyal U; Cheung MK; Suszko J; Laughlin B; Kim Y; Askam J; Arif-Tiwari H; Slane B; Gordon J; Stea B
    J Contemp Brachytherapy; 2021 Oct; 13(5):497-503. PubMed ID: 34759973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mould-based surface high-dose-rate brachytherapy for eyelid carcinoma.
    Vavassori A; Riva G; Durante S; Fodor C; Comi S; Cambria R; Cattani F; Spadola G; Orecchia R; Jereczek-Fossa BA
    J Contemp Brachytherapy; 2019 Oct; 11(5):443-448. PubMed ID: 31749853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds.
    Guix B; Finestres F; Tello J; Palma C; Martinez A; Guix J; Guix R
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):95-102. PubMed ID: 10758310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose brachytherapy with non sealed
    Castellucci P; Savoia F; Farina A; Lima GM; Patrizi A; Baraldi C; Zagni F; Vichi S; Pettinato C; Morganti AG; Strigari L; Fanti S
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1511-1521. PubMed ID: 33140131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofractionated high-dose-rate plesiotherapy in nonmelanoma skin cancer treatment.
    Arenas M; Arguís M; Díez-Presa L; Henríquez I; Murcia-Mejía M; Gascón M; Gómez D; Lafuerza A; Mur E; Azón A; Rovirosa À; Sabater S
    Brachytherapy; 2015; 14(6):859-65. PubMed ID: 26489922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.